查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1926918

非接触式生命征象检测器市场：按技术、组件、应用和最终用户划分 - 全球预测（2026-2032 年）

Non-contact Vital Signs Detector Market by Technology, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年非接触式生命征象检测器市值为 3.388 亿美元，预计到 2026 年将成长至 3.6883 亿美元，到 2032 年预计将达到 6.6758 亿美元，复合年增长率为 10.17%。

关键市场统计数据
基准年 2025 3.388亿美元
预计年份：2026年 3.6883亿美元
预测年份 2032 6.6758亿美元
复合年增长率 (%) 10.17%

这本权威入门读物说明了非接触式生命征象检测技术的基本原理、相关人员的期望和监管因素，并涵盖了临床和消费者领域的技术趋势。

非接触式生命征象侦测技术已从一个小众研究领域发展成为医疗保健、家用电子电器、汽车安全和国防等领域交叉融合的多维前沿技术。感测器精度、讯号处理和机器学习的最新进展使得无需直接接触皮肤即可采集心率、呼吸频率和运动相关生物标记物，从而为临床和非临床环境下的连续监测开闢了新途径。随着该技术的应用范围不断扩大，相关人员面临着临床检验要求、监管路径和隐私考虑等诸多复杂因素的相互作用，这些因素将决定这些系统从试点部署到家庭、医院和公共场所常规使用的速度。

模态融合、边缘人工智慧成熟度和监管政策的明朗化正在重塑非接触式健康监测的产品蓝图和临床应用路径。

非接触式生命征象检测领域正经历变革性的转折点，主要得益于技术融合、法规演变和使用者期望的改变。雷达、热成像、声学感测和影像分析等核心感测器技术不再孤立存在，开发人员通常会将多种测量技术融合起来，以弥补各自的局限性，并在实际环境中实现高精度输出。同时，边缘运算和最佳化的数位讯号处理技术能够实现低延迟推理，并降低对云端连接的依赖，从而增强隐私保护，并支援在频宽受限的环境中部署。

评估2025年关税调整如何影响非接触式生命征象系统的供应链韧性、模组化设计应用与筹资策略。

2025年实施的关税政策为支持非接触式生命征象检测系统的全球供应链带来了显着的复杂性。雷达模组、热感成像器、相机模组以及某些类型的半导体等组件通常从国际供应商采购，进口关税的变化将对到岸成本、组件筹资策略和供应商关係产生重大影响。为此，製造商和系统整合商正在采取各种战术性和战略措施来降低风险，包括将关键组装流程迁回国内、签订长期供应协议以及在不同司法管辖区寻找替代供应商。

有针对性的細項分析揭示了技术模式选择、应用场景、组件配置和最终用户期望如何影响产品策略和商业化。

市场区隔提供的洞察揭示了创新和商业性重点的集中领域，以及产品策略如何与最终用户期望相契合。从技术角度来看，开发人员优先考虑基于雷达的系统和热成像技术，同时也不断改进映像基础的方法。在基于雷达的系统中，连续波雷达、调频连续波雷达和超宽频雷达在渗透性、解析度和抗干扰能力方面各有优劣，解决方案设计人员会根据特定应用场景选择合适的模式。热成像系统分为长波红外线和短波红外线技术，每个波段对环境条件和临床目标的敏感度各不相同。映像基础的系统包括热成像摄影机和RGB摄影机。这些成像模式与先进影像处理演算法的结合，正在拓展基于摄影机的检测技术的应用范围，使其不再局限于受控环境。

区域策略指南：说明不同的管理体制、製造优势和医疗保健服务模式如何影响非接触式生命征象检测系统的采用和商业化决策

区域趋势对于确定非接触式生命征象检测系统的技术采纳路径、采购决策和监管协调至关重要。在美洲，由综合医疗网络、私人支付方、Start-Ups和成熟的医疗设备製造商组成的强大生态系统，为医疗技术的采纳提供了强有力的支持。这种环境虽然有利于快速进行试点计画并与临床系统建立合作关係，但也对供应商提出了严格的报销要求和合规性预期，从而影响产品规格和证据产生策略。

评估组件创新者相对于平台提供者的竞争角色：重点关注策略联盟、垂直整合和软体主导的差异化

非接触式生命征象侦测领域的竞争格局由专业组件供应商、系统整合商、软体平台供应商和研究机构共同构成。提供高性能雷达晶片、热感测器和相机模组的组件供应商在上游工程，他们掌控着决定设备製造商可用精度和成本的蓝图。系统整合商和原始设备製造商 (OEM) 则致力于建立一个强大的技术栈，平衡感测器融合、嵌入式处理和认证演算法，以满足各种应用的需求。

非接触式监测领域市场领导可采取切实可行的策略，以增强韧性、加速临床应用并建构软体差异化优势。

产业领导者应采取切实可行的措施，在短期韧性和长期差异化之间取得平衡。首先，他们应投资于模组化架构，将感测器模组与处理和分析层分开。这样，在供应链发生变化或关税压力增加时，即可快速进行替换。这种方法不仅可以降低组件风险，还支援「软体优先」的商业化模式，并透过分析和临床支援服务产生收入。

采用严谨的混合方法，结合相关人员访谈、技术文献综述、专利分析和情境测试，以验证检验并找出证据缺口。

本分析的调查方法结合了结构化的检验流程，以确保其稳健性和透明度，并辅以多方面的证据基础。主要研究包括对工程师、临床使用者、采购负责人和监管专家的访谈，以收集关于性能要求、整合挑战和应用驱动因素的第一手资料。此外，还对已发表的检验研究、白皮书和标准文件进行了技术审查，以补充这些定性见解，从而支持对感测器功能和演算法方法的评估。

摘要强调了技术融合、临床检验和供应链韧性是决定非接触式监测持续商业性成功的关键因素

总之，非接触式生命征象检测技术正处于一个转折点。技术成熟度、临床需求和地缘政治因素相互交织，既带来了机会，也带来了挑战。多模态感测和边缘运算分析技术正在拓展其应用范围，而日益严格的监管和隐私保护要求也提高了临床检验和系统设计的标准。 2025年关税相关的变化凸显了供应链柔软性和模组化架构的重要性，促使许多企业重新评估其采购和製造策略，并专注于提升韧性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 非接触式生命征象检测器市场（依技术划分）

  • 声波感测器
  • 基于雷达的系统
    • 连续波雷达
    • 调频连续波雷达
    • 超宽频雷达
  • 热成像系统
    • 长波红外线
    • 短波红外线
  • 映像基础的系统
    • 红外线摄影机
    • RGB相机

9. 非接触式生命征象检测器市场（依组件划分）

  • 处理器
    • 数位讯号处理器
    • 现场可程式闸阵列
    • 微控制器
  • 感应器
    • 声波感测器
    • 相机模组
    • 雷达感测器
    • 热感应器
  • 软体
    • 开放原始码平台
    • 专有平台

第十章 非接触式生命征象检测器市场（依应用领域划分）

  • 汽车安全
  • 家用电子电器
  • 卫生保健
    • 家庭监控
    • 医院监测
    • 远端患者监护
  • 军事/国防

第十一章 非接触式生命征象检测器市场（依最终用户划分）

  • 门诊治疗中心
  • 家庭用户
  • 医院
  • 研究所

第十二章 非接触式生命征象检测器市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 非接触式生命征象检测器市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国非接触式生命征象检测器市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 美国非接触式生命征象检测器市场

第十六章 中国非接触式生命征象检测器市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Baxter International Inc.
  • Dragerwerk AG & Co. KGaA
  • EarlySense Ltd.
  • General Electric Company
  • Honeywell International Inc.
  • Koninklijke Philips NV
  • Neteera Technologies Ltd
  • Nihon Kohden Corporation
  • OMRON HEALTHCARE Co., Ltd.
  • Teledyne Technologies Incorporated
  • Vayyar Imaging Ltd.
  • Xandar Kardian Ltd.
Product Code: MRR-4F7A6D4FF37C

The Non-contact Vital Signs Detector Market was valued at USD 338.80 million in 2025 and is projected to grow to USD 368.83 million in 2026, with a CAGR of 10.17%, reaching USD 667.58 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 338.80 million
Estimated Year [2026] USD 368.83 million
Forecast Year [2032] USD 667.58 million
CAGR (%) 10.17%

An authoritative primer on the technological foundations, stakeholder expectations, and regulatory drivers shaping non-contact vital signs detection across clinical and consumer domains

Non-contact vital signs detection has evolved from a niche research pursuit into a multidimensional technology frontier that intersects healthcare, consumer electronics, automotive safety, and defense. Recent advances in sensor fidelity, signal processing, and machine learning have made it possible to capture heart rate, respiratory rate, and motion-related biomarkers without direct skin contact, creating new modalities for continuous monitoring across clinical and nonclinical settings. As adoption broadens, stakeholders face a complex interplay of clinical validation requirements, regulatory pathways, and privacy considerations that will determine how rapidly these systems move from pilot deployments to routine use in homes, hospitals, and public spaces.

At the same time, the ecosystem supporting non-contact detection is expanding. Integrators combine radar, thermal, acoustic, and video modalities to improve robustness across lighting, movement, and occlusion scenarios, while edge-focused software architectures enable near-real-time analytics that reduce latency and preserve bandwidth. This introductory section frames the strategic context for the subsequent deep dives by outlining the principal technology classes, typical application domains, and the component stacks that enable deployment. It highlights the shifting expectations of end users-from clinicians who require validated performance under diverse physiological conditions to consumers seeking unobtrusive health insights-and underscores why interoperability and data governance are now core commercial requirements.

Looking ahead, the sector's trajectory will hinge on several cross-cutting dynamics: the maturation of regulatory frameworks for algorithmic medical devices, the ability of suppliers to secure resilient component sources, and the willingness of purchasers to integrate non-contact outputs into clinical workflows. This introduction positions those dynamics as the anchors of the report's analysis and sets the stage for understanding the transformative shifts, tariff impacts, segmentation insights, and regional considerations that follow.

How modality convergence, edge AI maturation, and regulatory clarity are reshaping product roadmaps and clinical adoption pathways for non-contact health monitoring

The landscape for non-contact vital signs detection is undergoing transformative shifts driven by technological convergence, regulatory evolution, and changing user expectations. Core sensor technologies-radar, thermal imaging, acoustic sensing, and video analytics-are no longer siloed; developers routinely fuse modalities to mitigate individual limitations and to deliver higher-fidelity outputs in real-world environments. Concurrently, edge computing and optimized digital signal processing allow for lower-latency inference and reduced dependency on cloud connectivity, which enhances privacy protections and supports deployment in bandwidth-constrained contexts.

Artificial intelligence models have transitioned from proof-of-concept prototypes to clinically oriented architectures that emphasize interpretability, robustness, and explainability. This shift reflects a growing demand from clinicians and procurement teams for algorithms that can justify decisions and integrate into electronic health records. Moreover, the push for regulatory clarity is encouraging manufacturers to adopt documentation and validation practices consistent with medical device pathways, accelerating the translation of experimental systems into cleared or certified products. As adoption accelerates, interoperability standards and data governance frameworks are emerging as critical enablers for multi-vendor ecosystems, shifting competition from isolated feature advances to platform-level compatibility and secure data exchange.

Finally, market momentum is being shaped by end-user preferences. Patients and caregivers increasingly favor unobtrusive monitoring solutions that preserve dignity and convenience, while healthcare systems prioritize tools that reduce staff burden and enable earlier intervention. Together, these forces are rapidly redefining product roadmaps, procurement criteria, and partnership strategies, creating a landscape where agility in technology integration and clarity in clinical value propositions determine commercial success.

Assessing how 2025 tariff adjustments are catalyzing supply chain resilience efforts, modular design adoption, and procurement strategies in non-contact vital signs systems

Tariff policies introduced in 2025 have introduced a notable layer of complexity into the global supply chains that underpin non-contact vital signs detection systems. Components such as radar modules, thermal imagers, camera modules, and certain semiconductor classes are often sourced from international suppliers, and changes in import duties can materially alter landed costs, component sourcing strategies, and supplier relationships. In response, manufacturers and integrators have pursued a range of tactical and strategic measures to mitigate exposure, including reshoring key assembly operations, negotiating long-term supply contracts, and qualifying alternative suppliers in different jurisdictions.

These adaptive responses are accompanied by operational trade-offs. Sourcing shifts can reduce tariff risk, but they may introduce higher fixed costs, require capital investment in new manufacturing lines, or necessitate requalification of components for regulatory submissions. Procurement teams have increasingly adopted total-cost-of-ownership frameworks that incorporate tariff scenarios, logistics volatility, and quality assurance demands. Parallel to supplier diversification, companies have accelerated efforts to increase localization of software development and firmware maintenance, thereby reducing reliance on cross-border service arrangements that could be impacted by trade policy changes.

From a strategic perspective, tariffs have reinforced the importance of modular design and supplier-agnostic hardware architectures that enable rapid substitution of sensors or processors without extensive system reengineering. Firms are also investing in deeper inventory planning capabilities and flexible manufacturing to buffer against episodic duty changes. Finally, the policy environment has prompted closer collaboration between commercial leaders and regulatory affairs teams, ensuring that any supply chain modifications do not compromise clinical validations or device compliance. Taken together, these adjustments reflect a sector that is adapting to tariff-driven cost pressures through structural changes that prioritize resilience and compliance over short-term cost minimization.

Targeted segmentation analysis revealing how technology modality choices, application contexts, component stacks, and end-user expectations shape product strategy and commercialization

Insights derived from the market's segmentation reveal where innovation and commercial focus are concentrated and how product strategies are aligning with end-user expectations. When segmentation is viewed through the lens of technology, developers are prioritizing radar-based systems and thermal imaging while continuing to refine acoustic and video-based approaches. Within radar-based systems, continuous wave radar, frequency modulated continuous wave radar, and ultra-wideband radar each offer distinct trade-offs in terms of penetration, resolution, and susceptibility to interference, prompting solution architects to select modalities according to intended use cases. Thermal imaging systems split between long wave infrared and short wave infrared technologies, with each band offering differential sensitivity to environmental conditions and clinical targets. Video-based systems encompass both infrared cameras and RGB cameras, and the pairing of these imaging modalities with advanced image processing algorithms has broadened the applicability of camera-based detection beyond controlled settings.

From an application standpoint, commercial focus spans automotive safety, consumer electronics, healthcare, and military and defense. Healthcare applications deserve particular attention because they diversify across home monitoring, hospital monitoring, and remote patient monitoring, each setting imposing distinct requirements for accuracy, latency, and integration with care pathways. This variance in deployment context directs product strategies toward either consumer-grade affordability and ease of use or clinical-grade accuracy and regulatory robustness.

Component segmentation-processors, sensors, and software-illuminates where value accrues within the product stack. Processors encompass digital signal processors, field programmable gate arrays, and microcontrollers, all of which influence latency, power consumption, and on-device inference capabilities. Sensor segmentation includes acoustic sensors, camera modules, radar sensors, and thermal sensors, and choices here determine baseline signal quality and environmental tolerance. Software is bifurcated into open source and proprietary platforms; open source frameworks facilitate rapid prototyping and community validation, while proprietary platforms provide differentiated analytics, clinical support tools, and integration capabilities that can underpin commercial defensibility.

Finally, end-user segmentation across ambulatory care centers, home users, hospitals, and research institutions reflects divergent procurement cycles and performance expectations. Ambulatory care centers and hospitals emphasize interoperability with clinical workflows and evidence-based performance, research institutions often prioritize experimental flexibility and access to raw data streams, and home users demand user experience and data privacy assurances. Understanding these segmented dynamics enables companies to tailor product roadmaps, certification strategies, and go-to-market approaches to the requirements of each customer cohort.

A regional strategic playbook showing how distinct regulatory regimes, manufacturing strengths, and healthcare delivery models influence adoption and commercialization decisions

Regional dynamics are instrumental in determining technology adoption pathways, procurement decisions, and regulatory alignment for non-contact vital signs detection systems. In the Americas, a strong health technology adoption curve is supported by integrated care networks, private payers, and a robust ecosystem of startups and established medical device companies. This environment favors rapid pilot implementations and partnerships with clinical systems, but it also subjects vendors to rigorous reimbursement and compliance expectations that influence product specifications and evidence generation strategies.

Europe, Middle East & Africa present a heterogeneous mix of regulatory regimes and healthcare delivery models that require nuanced market-entry plans. The European regulatory landscape increasingly emphasizes conformity to harmonized standards and clinical evidence, while Middle Eastern markets may prioritize rapid deployment for telemedicine and defense-related applications. Across EMEA, data protection regulations and cultural expectations around monitoring in public and private spaces shape product features and privacy-by-design approaches.

Asia-Pacific is characterized by a diverse set of market maturities, from highly advanced technology clusters to rapidly developing healthcare infrastructures. Several countries in the region have strong manufacturing bases for sensors and electronic components, which can lower production costs and shorten supply chains. This manufacturing proximity also fosters iterative hardware innovation and strategic partnerships. However, regional regulatory variability and competing national standards require deliberate localization strategies for clinical validation and after-sales support. Collectively, these regional distinctions guide where companies prioritize investments in clinical trials, manufacturing capacity, distribution partnerships, and local regulatory expertise.

An assessment of competitive roles from component innovators to platform providers highlighting strategic partnerships, vertical integration, and software-driven differentiation

Competitive dynamics in non-contact vital signs detection are shaped by a mix of specialized component suppliers, systems integrators, software platform providers, and research-focused institutions. Component suppliers that deliver high-performance radar chips, thermal sensors, and camera modules occupy a critical upstream role, as their roadmaps determine the fidelity and cost base available to device manufacturers. Systems integrators and original equipment manufacturers focus on assembling resilient stacks that balance sensor fusion, embedded processing, and certified algorithms to meet the needs of different applications.

Software platform providers play a pivotal role by offering analytics, device management, and clinical decision support layers that can either be packaged with hardware or licensed independently. The choice between open and proprietary software models is central to commercial differentiation; some firms emphasize rapid adoption through open frameworks and developer ecosystems, while others anchor enterprises on proprietary suites that promise validated clinical workflows and enterprise-grade support. Research institutions and specialized labs continue to push the envelope on algorithmic performance, and their collaborations with industry partners frequently lead to early-stage intellectual property and pilot deployments that drive longer-term commercial roadmaps.

Across this constellation of players, strategic alliances and co-development agreements have become more common, as companies seek to combine domain expertise in sensing, clinical validation, and regulatory affairs. This collaboration model reduces time to market for complex solutions and spreads the burden of evidence generation across partners. As a result, winning strategies increasingly emphasize vertical integration where it creates distinct value, complemented by selective partnerships to fill capability gaps and accelerate market entry.

Practical strategic moves for market leaders to enhance resilience, accelerate clinical adoption, and build software-enabled differentiation in non-contact monitoring

Industry leaders should pursue a set of actionable moves that balance near-term resilience with long-term differentiation. First, invest in modular architectures that decouple sensor modules from processing and analytics layers, enabling rapid substitution when supply chain or tariff pressures shift. This approach not only mitigates component risk but also supports a software-first commercialization model that can deliver ongoing revenue through analytics and clinical support services.

Second, prioritize clinical validation pathways early in product development to reduce time-to-adoption in regulated healthcare environments. Early investment in prospective studies, real-world evidence collection, and transparent algorithmic validation builds credibility with clinicians and procurement teams and accelerates reimbursement conversations. In parallel, embed privacy-by-design principles and interoperable data standards to address institutional and consumer concerns about data governance, thereby lowering barriers to integration with electronic health records and enterprise monitoring platforms.

Third, adopt a diversified supplier strategy that blends regional manufacturing capacity with qualified alternative vendors to absorb tariff and logistical shocks. Complement this with inventory and production flexibility that allows for scaling according to demand while preserving quality controls necessary for clinical use. Finally, cultivate partnerships with care providers and research institutions to co-develop use cases and to validate outcomes metrics that matter to payers and clinicians. These collaborations can produce compelling case studies that support commercialization and broaden clinical acceptance. Taken together, these actions provide a roadmap for leaders to navigate operational uncertainty while building defensible, clinically oriented products.

A rigorous mixed-methods approach combining stakeholder interviews, technical literature review, patent analysis, and scenario testing to validate conclusions and identify evidence gaps

The research methodology underpinning this analysis combines a multi-source evidence base with structured validation processes designed to ensure robustness and transparency. Primary research included interviews with engineers, clinical users, procurement officers, and regulatory specialists to capture first-hand perspectives on performance requirements, integration challenges, and adoption drivers. These qualitative insights were complemented by technical reviews of published validation studies, white papers, and standards documents to ground assessments of sensor capabilities and algorithmic approaches.

Secondary research encompassed patent landscaping, supplier roadmaps, and public filings to identify technology trajectories and strategic positioning among component and platform providers. Attention was paid to peer-reviewed literature and conference proceedings to validate claims of clinical performance and to surface emerging evaluation frameworks. The methodology also incorporated scenario analysis to assess the implications of supply chain shocks and policy shifts, enabling a structured view of tactical responses and their operational trade-offs.

Finally, findings were triangulated through stakeholder workshops that reviewed preliminary conclusions and identified potential blind spots. Throughout the process, care was taken to document assumptions, to note areas of evidence scarcity, and to flag topics requiring further primary investigation. This layered approach ensures that the report's conclusions are rooted in a blend of practitioner experience, technical evidence, and strategic foresight.

Concluding synthesis emphasizing the convergence of technology, clinical validation, and supply chain resilience as the determinants of sustained commercial success in non-contact monitoring

In conclusion, non-contact vital signs detection is at an inflection point where technological maturity, clinical demand, and geopolitical factors converge to create both opportunity and complexity. Multi-modal sensing and edge-capable analytics have expanded the universe of feasible applications, while regulatory and privacy expectations are elevating the bar for clinical validation and system design. Tariff-related shifts in 2025 have underscored the importance of supply chain flexibility and modular architectures, prompting many organizations to re-evaluate sourcing and manufacturing strategies in favor of resilience.

Segmentation insights indicate that differentiated product strategies-whether focused on radar-intensive clinical deployments, thermal-enabled safety integrations, or software-led consumer experiences-will determine competitive positioning. Regional dynamics further complicate the picture, as distinct regulatory regimes and manufacturing ecosystems require deliberate localization and partnership strategies. Competitive advantage will accrue to organizations that can combine high-quality sensing hardware with validated analytics, strong clinical evidence, and pragmatic commercialization plans tailored to local market conditions.

Ultimately, success in this sector will depend on the ability to translate technological promise into demonstrable clinical value while managing operational risks. Companies that align product development with rigorous validation, execute on flexible supply chain strategies, and engage closely with clinical stakeholders will be best positioned to capture the long-term benefits of non-contact vital signs monitoring across healthcare and adjacent markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-contact Vital Signs Detector Market, by Technology

  • 8.1. Acoustic Sensors
  • 8.2. Radar Based Systems
    • 8.2.1. Continuous Wave Radar
    • 8.2.2. Frequency Modulated Continuous Wave Radar
    • 8.2.3. Ultra Wideband Radar
  • 8.3. Thermal Imaging Systems
    • 8.3.1. Long Wave Infrared
    • 8.3.2. Short Wave Infrared
  • 8.4. Video Based Systems
    • 8.4.1. Infrared Cameras
    • 8.4.2. Rgb Cameras

9. Non-contact Vital Signs Detector Market, by Component

  • 9.1. Processors
    • 9.1.1. Digital Signal Processor
    • 9.1.2. Field Programmable Gate Array
    • 9.1.3. Microcontroller
  • 9.2. Sensors
    • 9.2.1. Acoustic Sensors
    • 9.2.2. Camera Modules
    • 9.2.3. Radar Sensors
    • 9.2.4. Thermal Sensors
  • 9.3. Software
    • 9.3.1. Open Source Platform
    • 9.3.2. Proprietary Platform

10. Non-contact Vital Signs Detector Market, by Application

  • 10.1. Automotive Safety
  • 10.2. Consumer Electronics
  • 10.3. Healthcare
    • 10.3.1. Home Monitoring
    • 10.3.2. Hospital Monitoring
    • 10.3.3. Remote Patient Monitoring
  • 10.4. Military And Defense

11. Non-contact Vital Signs Detector Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Home Users
  • 11.3. Hospitals
  • 11.4. Research Institutions

12. Non-contact Vital Signs Detector Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Non-contact Vital Signs Detector Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Non-contact Vital Signs Detector Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Non-contact Vital Signs Detector Market

16. China Non-contact Vital Signs Detector Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Baxter International Inc.
  • 17.6. Dragerwerk AG & Co. KGaA
  • 17.7. EarlySense Ltd.
  • 17.8. General Electric Company
  • 17.9. Honeywell International Inc.
  • 17.10. Koninklijke Philips N.V.
  • 17.11. Neteera Technologies Ltd
  • 17.12. Nihon Kohden Corporation
  • 17.13. OMRON HEALTHCARE Co., Ltd.
  • 17.14. Teledyne Technologies Incorporated
  • 17.15. Vayyar Imaging Ltd.
  • 17.16. Xandar Kardian Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONTINUOUS WAVE RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FREQUENCY MODULATED CONTINUOUS WAVE RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ULTRA WIDEBAND RADAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY LONG WAVE INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SHORT WAVE INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY INFRARED CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RGB CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY DIGITAL SIGNAL PROCESSOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY FIELD PROGRAMMABLE GATE ARRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MICROCONTROLLER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY ACOUSTIC SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CAMERA MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY OPEN SOURCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROPRIETARY PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AUTOMOTIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY CONSUMER ELECTRONICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY MILITARY AND DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOME USERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 231. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 233. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 267. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 268. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 279. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS, 2018-2032 (USD MILLION)
  • TABLE 280. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 281. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 284. NATO NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY RADAR BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY THERMAL IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY VIDEO BASED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES NON-CONTACT VITAL SIGNS DETECTOR MARKET SIZE, BY PROCESSORS,